Agarwal Arjun's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Jul 13, 2026
- Accession no.
- 0000907654-26-000071
- Filed
- Jul 13, 2026, 5:09 PM ET
- Trade date
- Jul 13, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $846.2K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agarwal ArjunCIK 0002033974 | Officer (Senior Vice President, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Common Stock | MOption exerciseAcquired | +8,541 | $12.50 | +$106,762.5 | 23,853 | Direct | |
| Jul 13, 2026 | Common Stock | MOption exerciseAcquired | +1,458 | $34.39 | +$50,140.62 | 25,311 | Direct | |
| Jul 13, 2026 | Common Stock | SSaleDisposed | −300 | $83.07 | −$24,919.95 | 25,011 | Direct | |
| Jul 13, 2026 | Common Stock | SSaleDisposed | −3,743 | $84.26 | −$315,369.09 | 21,268 | Direct | |
| Jul 13, 2026 | Common Stock | SSaleDisposed | −5,656 | $84.90 | −$480,201.19 | 15,612 | Direct | |
| Jul 13, 2026 | Common Stock | SSaleDisposed | −300 | $85.63 | −$25,689.99 | 15,312 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Common Stock | MOption exerciseDisposed | −8,541 | $0.00 | $0 | 101,459 | Direct | |
| Jul 13, 2026 | Common Stock | MOption exerciseDisposed | −1,458 | $0.00 | $0 | 61,250 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.